印度对人类疫苗的紧急批准机制
Nidhi Mehrotra1, Padmavati Manchikanti2
1Rajiv Gandhi School of Intellectual Property Law, Indian Institute of Technology Kharagpur, Kharagpur, 721302, India. nidhimehrotra11@gmail.com.
Pharmaceutical medicine
|January 24, 2024
概括
印度 印度 印度
科学领域:
- 监管科学 监管科学
- 公共卫生政策 公共卫生政策
- 疫苗开发 疫苗开发
背景情况:
- COVID-19大流行暴露了管理公共卫生紧急情况 (PHE) 的全球脆弱性.
- 在疫情期间,及时获得医疗疗法,特别是疫苗,被证明是至关重要的.
- 印度实施了紧急批准途径,包括滚动和加速审查,以加快疫苗获取.
研究的目的:
- 审查印度2019年新药和临床试验规则在紧急COVID-19疫苗批准方面的使用情况.
- 探索印度PHEs期间紧急疫苗授权的法律基础.
- 为了确定印度现有的"紧急使用"框架中的挑战和复杂性.
主要方法:
- 审查2019年新药和临床试验规则.
- 分析印度药品总监局 (DCGI) 针对COVID-19疫苗的紧急批准流程.
- 评估紧急使用授权的立法基础.
主要成果:
- 2019年新药和临床试验规则为印度的COVID-19疫苗紧急批准提供了一个框架.
- 采用了监管灵活性,数字化整合和适应的统计方法.
- 该研究确定了"紧急使用"范式的关键方面:定义,决策透明度和终止规则.
结论:
- 印度的监管框架在COVID-19 PHE期间表现出适应性.
- 提出了政策建议,以加强"紧急使用"框架,以应对未来的公共卫生威胁.
- 提高紧急使用的定义,决策透明度和终止协议至关重要.
更多相关视频
12:09Protocol for Recombinant RBD-based SARS Vaccines: Protein Preparation, Animal Vaccination and Neutralization Detection
Published on: May 2, 2011
42.9K
11:28Analysis of Iophenoxic Acid Analogues in Small Indian Mongoose Herpestes Auropunctatus Sera for Use as an Oral Rabies Vaccination Biological Marker
Published on: May 31, 2019
5.9K
相关概念视频
Vaccinations
44.5K
Overview
44.5K
Drug Regulation
1.4K
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
1.4K
Pharmacovigilance
833
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
833
Cross-reactivity
31.1K
Overview
31.1K
